AQP4 and relapsing-remitting multiple sclerosis: Furthermore, 3 out of 6 patients with RRMS were double positive for anti-MAP_2694295–303 and anti-MBP85–98 antibodies while only 1 patient with NMOSD (AQP4-negative, OCB-negative) showed antibodies against both peptides.